Nothing Special   »   [go: up one dir, main page]

WO2011091410A8 - Trpv4 antagonists - Google Patents

Trpv4 antagonists Download PDF

Info

Publication number
WO2011091410A8
WO2011091410A8 PCT/US2011/022380 US2011022380W WO2011091410A8 WO 2011091410 A8 WO2011091410 A8 WO 2011091410A8 US 2011022380 W US2011022380 W US 2011022380W WO 2011091410 A8 WO2011091410 A8 WO 2011091410A8
Authority
WO
WIPO (PCT)
Prior art keywords
trpv4 antagonists
trpv4
antagonists
indole
pharmaceutical compositions
Prior art date
Application number
PCT/US2011/022380
Other languages
French (fr)
Other versions
WO2011091410A1 (en
Inventor
Hilary Schneck Eidam
Ryan Michael Fox
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of WO2011091410A1 publication Critical patent/WO2011091410A1/en
Publication of WO2011091410A8 publication Critical patent/WO2011091410A8/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

The present invention relates to indole or benzothiophene analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.
PCT/US2011/022380 2010-01-25 2011-01-25 Trpv4 antagonists WO2011091410A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29786410P 2010-01-25 2010-01-25
US61/297,864 2010-01-25

Publications (2)

Publication Number Publication Date
WO2011091410A1 WO2011091410A1 (en) 2011-07-28
WO2011091410A8 true WO2011091410A8 (en) 2011-11-24

Family

ID=44307279

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/022380 WO2011091410A1 (en) 2010-01-25 2011-01-25 Trpv4 antagonists

Country Status (1)

Country Link
WO (1) WO2011091410A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2832731A4 (en) 2012-03-27 2015-08-19 Shionogi & Co Aromatic heterocyclic five-membered ring derivative having trpv4 inhibitory activity
WO2015046193A1 (en) 2013-09-25 2015-04-02 塩野義製薬株式会社 Aromatic heterocyclic amine derivative having trpv4 inhibiting activity
CN107074771B (en) * 2014-08-28 2020-03-20 X-化学有限公司 Soluble epoxide hydrolase inhibitors and uses thereof
DK3240785T3 (en) 2014-12-29 2021-09-27 Us Health SMALL MOLECULATE INHIBITORIES OF LACTASE DEHYDROGENASIS AND PROCEDURES FOR USE
WO2022014707A1 (en) 2020-07-16 2022-01-20 ラクオリア創薬株式会社 Trpv4 inhibitor as therapeutic drug for eye disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008512461A (en) * 2004-09-07 2008-04-24 スミスクライン・ビーチャム・コーポレイション New compounds
WO2007070865A2 (en) * 2005-12-15 2007-06-21 Smithkline Beecham Corporation Piperazine compounds as agonists of trpv4 channel receptors

Also Published As

Publication number Publication date
WO2011091410A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
JOP20180102B1 (en) Pharmaceutical composition
JO3154B1 (en) Trpv4 antagonists
WO2012140274A3 (en) Agonists and antagonists of the wnt pathway
WO2011017108A3 (en) Cyclopropyl modulators of p2y12 receptor
PL2590916T3 (en) Stable 2,3,3,3-tetrafluoropropene composition
PL2431442T3 (en) Composition of 1,3,3,3-tetrafluoropropene
GB201017345D0 (en) Receptor antagonists
IL230218A (en) Substituted azaheterocyclic compounds, their preparation and pharmaceutical compositions containing them
MY181898A (en) Heterocyclic compounds and uses thereof
IL224288A (en) Derivatives of substituted pyrazolamide, pharmaceutical compositions comprising the same and uses thereof
WO2010115552A8 (en) Bispecific anti-erbb-3/anti-c-met antibodies
IL214425A (en) Substituted bicyclic heterocyclic compounds, pharmaceutical compositions comprising them and uses thereof
MX2011008864A (en) Sulfonylated tetrahydroazolopyrazines and their use as medicinal products.
EP2702054A4 (en) Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
MX2011014019A (en) Diazahomoadamantane derivatives and methods of use thereof.
WO2009089234A3 (en) Substituted dibenzhydrylpiperazines
WO2010144477A3 (en) Sulfonylurea modulators of endothelin receptor
MX2012013855A (en) Oligo-benzamide compounds and their use.
IN2012DN02793A (en)
PL2646520T3 (en) Compositions containing 1,1,1,4,4,4-hexafluorobut-2-ene and 3,3,4,4,4- pentafluorobut-1-ene
EP2730555A4 (en) Composition containing 1,4-butanediol
IL235955B (en) Benzothiophene derivatives, their preparation and pharmaceutical compositions containing them
WO2011091410A8 (en) Trpv4 antagonists
MY165088A (en) Pharmaceutical compositions comprising alisporivir

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11735345

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11735345

Country of ref document: EP

Kind code of ref document: A1